Wageningen University
Wageningen, Gelderland, 6701 BH, Netherlands
NCT Number: NCT01240837
The purpose of this study is to determine by how much, the ingestion of palm sugar increases blood glucose concentrations and what the corresponding glycaemic index is. The investigators estimate that the glycaemic index will be 68 (equal to that of sucrose).
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Wageningen, Gelderland, 6701 BH, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
50 g palm sugar given orally 1 time in 250 ml of water. Blood glucose measurements will then be taken at time points, 0, 15, 30, 45, 60, 90 and 120 minutes.
Other names: palm sugar
50 g glucose given orally 3 time in 250 ml of water. Blood glucose measurements will then be taken at time points, 0, 15, 30, 45, 60, 90 and 120 minutes.
50 g sucrose given orally 1 time in 250 ml of water. Blood glucose measurements will then be taken at time points, 0, 15, 30, 45, 60, 90 and 120 minutes.
Other names: sugar, table sugar
Time frame: 2 months
During the labratory visits subjects will ingest glucose (control), sucrose or palm sugar. At time points 0, 15, 30, 45, 60, 90 and 120 minutes post ingestion blood glucose concentrations will be measured by finger prick blood samples.
Wageningen University
Other
Investigation of the Glycaemic Index of Arenga Pinnata Palm Sugar
Acronym: LIPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07695441
Healthy Adults, Postprandial Glycemic Response
Seongnam-si, Gyeonggi-do, South Korea
View Trial DetailsNCT07454551
Healthy Adults, Young
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05379101
Amyloid Neuropathies, Amyloid Neuropathies, Familial
Rochester, Minnesota, United States
View Trial DetailsNCT07636018
Healthy Adults
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial Details